Vimarsana
Biggest News Aggregation in the World

Page 3 - Executive Pascal Soriot News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Executive Pascal Soriot. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Executive Pascal Soriot Today - Breaking & Trending Today

AstraZeneca Launches Health-Tech Business Evinova to Support Clinical Studies - Vimarsana News

AstraZeneca Launches Health-Tech Business Evinova to Support Clinical Studies

By Michael Susin AstraZeneca said it has launched Evinova, a separate health-tech business to offer its knowledge of clinical trial design and study delivery. The Anglo-Swedish...

AstraZeneca Q2 results beat estimates; COVID vaccine sales evaporate - Vimarsana News

AstraZeneca Q2 results beat estimates; COVID vaccine sales evaporate

LONDON (Reuters) -AstraZeneca on Friday delivered better-than-expected profits and sales in the second quarter as a strong performance of its blockbuster cancer drugs helped offset the loss of COVID-19 vaccine sales. Total revenue in the quarter was $11.4 billion, up 6% and beating company-compiled analyst estimates of $10.97 billion. Shares were up 3.1% in early trading, among the top gainers on London's blue-chip FTSE stock index.

Source: yahoo.com
AstraZeneca second quarter profit beats expectations - Vimarsana News

AstraZeneca second quarter profit beats expectations

AstraZeneca on Friday beat expectations for its second-quarter profit, helped by better-than-expected sales of its oncology drugs. Each of our non-COVID-19 therapy areas saw...

AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up - AstraZeneca (NASDAQ:AZN), AstraZeneca (OTC:AZNCF) - Vimarsana News

AstraZeneca Q2 Earnings Beat Consensus Despite Zero COVID-19 Vaccine Sales, Stock Shoots Up - AstraZeneca (NASDAQ:AZN), AstraZeneca (OTC:AZNCF)

AstraZeneca Plc's (NASDAQ: AZN) unit Alexion has 

AstraZeneca profit jumps despite Covid-19 sales decline - Vimarsana News

AstraZeneca profit jumps despite Covid-19 sales decline

AstraZeneca PLC on Thursday said revenue decreased in the first quarter of the year as Covid-19 related sales dropped, but pretax profit surged. The Cambridge, UK-based pharmaceutical firm reported... | April 27, 2023